Track topics on Twitter Track topics that are important to you
Designation Recognizes Urologist Dr. Jonathan W. Agins’ Commitment to Exemplary Care, Deep UroLift Experience
Phoenix, Arizona (PRWEB) June 22, 2017
Valley Urologic Associates today announced that Dr. Jonathan Agins has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Agins has achieved a high level of training and experience with the UroLift System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia or BPH. Dr. Agins is the first physician in the state of Arizona to be designated a UroLift Center of Excellence.
“The UroLift System is a breakthrough, minimally invasive treatment for enlarged prostate,” said Agins. “Patients experience rapid results, are able to discontinue use of medications, and retain their sexual function. We are proud to be among the first to utilize the UroLift System and to be providing our patients with the quality of life they deserve.”
Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life.
Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.
Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.
To schedule a consultation with Dr. Agins, please call 623-935-5522.
About the UroLift System
NeoTract’s FDA-cleared UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.
About Valley Urologic Associates
Valley Urologic Associates, with urologists in Glendale at Arrowhead, Goodyear at West Valley, Phoenix at Paradise Valley, and in Buckeye, is the iconic urology practice of Shawn D. Blick MD, Jonathan Agins MD, Vi N. Hua MD, Rahul Thaly MD, Lynn W. Blunt, Jr. MD, Lipika McCauley MD, urologic oncologist Torre H. Rhoades MD and pediatric urologist Ben O. Donovan MD.
Our urologists combine extensive experience and the latest technological advances in addressing urological concerns. Our urologists and staff partner with patients in the treatment of adult and pediatric urologic disease. We strive to offer treatment that is state of the art with compassion and sensitivity. Our urologists are trained at the World's foremost institutions and are adept in all areas of urology, including Fellowship Trained specialization to address specific areas of urology such as da Vinci robotic surgery, urologic oncology, and pediatric urology.
# # #
For the original version on PRWeb visit: http://www.prweb.com/releases/2017/06/prweb14450337.htmNEXT ARTICLE
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...
Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...
The World Health Organization (WHO) definition of sexual health; "the state of physical, emotional, mental and social well-being related to sexuality; it is not merely the absence of disease, dysfunction and infirmity. Sexual health requires a posit...